NO994674L - Anvendelse av natriumkanalblokkeringsmiddel for fremstilling av et medikament for forhindring av optisk nervedegenering assosiert med glaucom - Google Patents

Anvendelse av natriumkanalblokkeringsmiddel for fremstilling av et medikament for forhindring av optisk nervedegenering assosiert med glaucom

Info

Publication number
NO994674L
NO994674L NO994674A NO994674A NO994674L NO 994674 L NO994674 L NO 994674L NO 994674 A NO994674 A NO 994674A NO 994674 A NO994674 A NO 994674A NO 994674 L NO994674 L NO 994674L
Authority
NO
Norway
Prior art keywords
glaucoma
medicament
prevention
manufacture
optic nerve
Prior art date
Application number
NO994674A
Other languages
English (en)
Other versions
NO994674D0 (no
Inventor
Joseph S Adorante
Original Assignee
Allergan Sales Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Sales Inc filed Critical Allergan Sales Inc
Publication of NO994674D0 publication Critical patent/NO994674D0/no
Publication of NO994674L publication Critical patent/NO994674L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO994674A 1997-03-27 1999-09-24 Anvendelse av natriumkanalblokkeringsmiddel for fremstilling av et medikament for forhindring av optisk nervedegenering assosiert med glaucom NO994674L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/827,194 US5922746A (en) 1997-03-27 1997-03-27 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma
PCT/US1998/005941 WO1998043612A1 (en) 1997-03-27 1998-03-26 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma

Publications (2)

Publication Number Publication Date
NO994674D0 NO994674D0 (no) 1999-09-24
NO994674L true NO994674L (no) 1999-11-25

Family

ID=25248552

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994674A NO994674L (no) 1997-03-27 1999-09-24 Anvendelse av natriumkanalblokkeringsmiddel for fremstilling av et medikament for forhindring av optisk nervedegenering assosiert med glaucom

Country Status (13)

Country Link
US (6) US5922746A (no)
EP (1) EP0973500A1 (no)
JP (1) JP2001521500A (no)
KR (1) KR100610997B1 (no)
CN (1) CN1251520A (no)
AU (1) AU734432B2 (no)
BR (1) BR9807895A (no)
CA (1) CA2284940A1 (no)
HU (1) HUP0001268A2 (no)
IL (1) IL132001A (no)
NO (1) NO994674L (no)
NZ (1) NZ337604A (no)
WO (1) WO1998043612A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001041756A2 (en) * 1999-12-02 2001-06-14 University Of South Florida Method and composition for treatment of ischemic neuronal reperfusion injury
GB0002666D0 (en) 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
US20060013814A1 (en) * 2000-08-29 2006-01-19 Davies Collison Cave Methods for preventing pressure-induced apoptotic neural-cell death
WO2002042842A2 (en) * 2000-11-22 2002-05-30 Allergan, Inc. A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels
US6479458B1 (en) * 2001-11-08 2002-11-12 Allergan, Inc. Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy
US7361478B2 (en) * 2001-11-20 2008-04-22 Allergan, Inc. High-throughput screen for identifying selective persistent sodium channels channel blockers
US20040058313A1 (en) * 2002-04-24 2004-03-25 Abreu Marcio Marc Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
WO2004093814A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a sodium channel blocker
US7125908B2 (en) * 2003-08-29 2006-10-24 Allergan, Inc. Treating pain using selective antagonists of persistent sodium current
BRPI0413920A (pt) * 2003-08-29 2006-10-24 Allergan Inc emprego de antagonistas seletivos de corrente de sódio persistente para tratar distúrbios neurológicos e dor
US7060723B2 (en) 2003-08-29 2006-06-13 Allergan, Inc. Treating neurological disorders using selective antagonists of persistent sodium current
CA2661448A1 (en) 2005-08-25 2007-03-01 Steven Michael Weiss Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
WO2016100209A1 (en) * 2014-12-15 2016-06-23 The Children's Medical Center Corporation Non-toxic topical anesthetic ophthalmic compositions
US10791651B2 (en) 2016-05-31 2020-09-29 Carbice Corporation Carbon nanotube-based thermal interface materials and methods of making and using thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06172176A (ja) * 1992-12-03 1994-06-21 Rohto Pharmaceut Co Ltd アジマリンを必須成分とする眼圧降下剤
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
JPH09510961A (ja) * 1994-01-14 1997-11-04 ジュニア シャヒニアン，リー 持続性および長期間の角膜鎮痛の方法

Also Published As

Publication number Publication date
US6426358B1 (en) 2002-07-30
EP0973500A1 (en) 2000-01-26
BR9807895A (pt) 2000-02-22
NO994674D0 (no) 1999-09-24
US20020040042A1 (en) 2002-04-04
IL132001A0 (en) 2001-03-19
CA2284940A1 (en) 1998-10-08
US6326389B1 (en) 2001-12-04
AU6776298A (en) 1998-10-22
AU734432B2 (en) 2001-06-14
US5922746A (en) 1999-07-13
US20020013353A1 (en) 2002-01-31
US6420402B2 (en) 2002-07-16
HUP0001268A2 (hu) 2000-12-28
KR20000076334A (ko) 2000-12-26
US20020137777A1 (en) 2002-09-26
JP2001521500A (ja) 2001-11-06
NZ337604A (en) 2001-03-30
US20020183368A1 (en) 2002-12-05
IL132001A (en) 2005-07-25
CN1251520A (zh) 2000-04-26
KR100610997B1 (ko) 2006-08-10
WO1998043612A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
NO994674D0 (no) Anvendelse av natriumkanalblokkeringsmiddel for fremstilling av et medikament for forhindring av optisk nervedegenering assosiert med glaucom
NO974507D0 (no) Farmasöytisk blanding med hudgjennomtrengende frigjöring
AU5732699A (en) Corneal onlay
NO20010556D0 (no) Fremgangsmåte for oftalmisk administrering
ZA966319B (en) Corneal irrigation cannula
GB2302018B (en) Ophthalmic pharmaceutical composition
BR9610836A (pt) Composição antibacterial para administração oral
DK0859615T3 (da) Carbostyrilderivat til helbredelse af ophthalmologiske sygdomme
EP1060748A4 (en) MEDICATIONS FOR CORNEAL EPITHELIUM DISORDERS
FI942400A0 (fi) Lääkeaine hermosairauksia vastaan
EP0791358A4 (en) REMEDY FOR OPHTHALMIC DISORDERS
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
AU3206195A (en) Optic nerve health
AU9566698A (en) Firefighter goggle
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
HUP0004647A3 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
EP0774260A4 (en) REMEDY FOR CORNEAL AFFECTIONS
WO2000010544A3 (en) A method for preventing the onset of asthma
GB2324385B (en) Goggle construction
KR970027081U (ko) 안전 귀마개
FI963271A (fi) 2-(4-metoksifenoksi)-3-pyridiiniamiini, sen valmistus ja sen käyttö tulehduslääkkeenä
AU1801299A (en) Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application